Global Drug R&D Intelligence Platform
Empowering Research Leaders to defy doubt with faster, data-driven decisions.
Causaly Pipeline Graph offers unparalleled access to the global R&D landscape paired with patented Scientific AI Search and summarization technology.
Discover how the world's largest pharmaceutical companies, including Novo Nordisk, UCB, and Teva Pharmaceuticals are embracing data driven decision making with Causaly. Your Pipeline Graph Trial will provide:
- Full visibility into 100,000+ therapeutics across modalities like ADCs, gene and cell therapies — unified into one AI-mapped landscape.
- Dynamic exploration of science behind landscapes — ask follow-ups and instantly compare efficacy, safety or preclinical insights via the AI Copilot.
- One-click exports in your preferred format to share competitive insight with leadership and teams.
Get your free customized trial
Trusted by the world's leading pharmaceutical companies

Confident Pipeline Decisions
“When one of our programs faced enrollment challenges, Pipeline Graph revealed a surge of new studies in the same indication. That context helped us explain the slowdown and make confident, evidence-based adjustments to our development plan.”
— Clinical Development Director - Top 10 Pharma
“I’ve used many established intelligence platforms over the years. They hold vast amounts of data, but retrieving a single specific insight often takes forever. With Causaly, it takes seconds — that’s a completely different experience.”
— Geneticist, European Biotech
Accelerate Time to Insight
— Associate Director, New Projects, Immunology & Neuroscience, Teva Pharmaceuticals
“I use Pipeline Graph in real time during 5–15 external meetings every week. It keeps our discussions sharper, our questions smarter, and our decisions faster.”


.png?width=1200&height=236&name=Causaly%20logo%20(Medium).png)